National campaign to raise awareness of actinic keratosis

Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) -- a potential early warning sign of skin cancer -- as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.

Graceway is the primary sponsor of the No. 15 NASCAR Camping World Truck Series Toyota Tundra for the remainder of the 2009 series season. "Aric is a tremendous driver and we are proud to work with him to help raise awareness of the realities of life-long sun exposure," said Jeff Gregory, CEO and Chairman, Graceway Pharmaceuticals.

AK is a visible sign of accumulated sun damage caused by harmful UV rays. Many people have never heard of AKs and yet these flat, scaly patches on the sun-exposed skin are the most commonly treated condition by dermatologists and are a leading diagnosis at skin cancer screenings.

  • It is estimated that about 10 million Americans currently have AK.
  • Anyone who has previously had an AK is at a higher risk for developing new AKs or skin cancer.
  • Approximately 10% of AKs may develop into a potentially life-threatening form of skin cancer called squamous cell carcinoma.
  • The incidence of AK is slightly higher in men, because they tend to spend more time in the sun and use less sun protection than women.

"I'm protected from the sun when I'm racing, but my fans aren't," said Almirola. "Because sun exposure is the cause of most skin cancers, fans should always use sunscreen and see a dermatologist for regular skin checks, especially if they notice something abnormal."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer